These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16756466)

  • 1. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07.
    Kula D; Bednarczuk T; Jurecka-Lubieniecka B; Polanska J; Hasse-Lazar K; Jarzab M; Steinhof-Radwanska K; Hejduk B; Zebracka J; Kurylowicz A; Bar-Andziak E; Stechly T; Pawlaczek A; Gubala E; Krawczyk A; Szpak-Ulczok S; Nauman J; Jarzab B
    Thyroid; 2006 May; 16(5):447-53. PubMed ID: 16756466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children.
    Iwama S; Ikezaki A; Kikuoka N; Kim HS; Matsuoka H; Yanagawa T; Sato H; Hoshi M; Sakamaki T; Sugihara S
    Horm Res; 2005; 63(2):55-60. PubMed ID: 15640608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population.
    Petrone A; Giorgi G; Galgani A; Alemanno I; Corsello SM; Signore A; Di Mario U; Nisticò L; Cascino I; Buzzetti R
    Thyroid; 2005 Mar; 15(3):232-8. PubMed ID: 15785242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population.
    Petrone A; Giorgi G; Mesturino CA; Capizzi M; Cascino I; Nistico L; Osborn J; Di Mario U; Buzzetti R
    Thyroid; 2001 Feb; 11(2):171-5. PubMed ID: 11288988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of HLA-DRB1* alleles and CTLA4 (+49 AG) gene polymorphism in Autoimmune Thyroid Disease.
    Ramgopal S; Rathika C; Padma MR; Murali V; Arun K; Kamaludeen MN; Balakrishnan K
    Gene; 2018 Feb; 642():430-438. PubMed ID: 29174716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children.
    Mochizuki M; Amemiya S; Kobayashi K; Kobayashi K; Shimura Y; Ishihara T; Nakagomi Y; Onigata K; Tamai S; Kasuga A; Nanazawa S
    Diabetes Care; 2003 Mar; 26(3):843-7. PubMed ID: 12610047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds.
    Maciel LM; Rodrigues SS; Dibbern RS; Navarro PA; Donadi EA
    Thyroid; 2001 Jan; 11(1):31-5. PubMed ID: 11272094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.
    Chen QY; Huang W; She JX; Baxter F; Volpe R; Maclaren NK
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3182-6. PubMed ID: 10487684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immune regulatory genes in familial and sporadic Graves' disease.
    Ban Y; Concepcion ES; Villanueva R; Greenberg DA; Davies TF; Tomer Y
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4562-8. PubMed ID: 15356063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between HLA class II haplotype with Graves' disease in Thai population.
    Wongsurawat T; Nakkuntod J; Charoenwongse P; Snabboon T; Sridama V; Hirankarn N
    Tissue Antigens; 2006 Jan; 67(1):79-83. PubMed ID: 16451208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
    Agarwal K; Czaja AJ; Jones DE; Donaldson PT
    Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy.
    Bednarczuk T; Hiromatsu Y; Seki N; Płoski R; Fukutani T; Kuryłowicz A; Jazdzewski K; Chojnowski K; Itoh K; Nauman J
    Hum Immunol; 2004 Jun; 65(6):632-9. PubMed ID: 15219383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.
    Yarman S; Oguz F; Carin M
    Int J Immunogenet; 2007 Feb; 34(1):23-5. PubMed ID: 17284224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Graves' disease in a patient under immunosuppressive therapy after liver transplantation.
    Bednarczuk T; Makowska U; Nauman J
    J Endocrinol Invest; 2003 Mar; 26(3):257-60. PubMed ID: 12809177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-DR and -DQ genes with Graves disease in Koreans.
    Park MH; Park YJ; Song EY; Park H; Kim TY; Park DJ; Park KS; Cho BY
    Hum Immunol; 2005 Jun; 66(6):741-7. PubMed ID: 15993720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
    Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
    Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease.
    Takara M; Kouki T; DeGroot LJ
    Thyroid; 2003 Dec; 13(12):1083-9. PubMed ID: 14751028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
    Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H
    Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease.
    Philippou G; Krimitzas A; Kaltsas G; Anastasiou E; Souvatzoglou A; Alevizaki M
    J Endocrinol Invest; 2001 Feb; 24(2):88-91. PubMed ID: 11263477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.